Veru Inc
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 189
- Market Cap
- $122.9M
- Introduction
Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed for two ...
Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Veru Inc.
- Target Recruit Count
- 93
- Registration Number
- NCT03646162
- Locations
- 🇺🇸
Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸Houston Urology Partners, Houston, Texas, United States
🇺🇸Urology of Virginia, Virginia Beach, Virginia, United States
© Copyright 2024. All Rights Reserved by MedPath